Genmab - Stock Price History | GMAB

Historical daily share price chart and data for Genmab since 2023 adjusted for splits. The latest closing stock price for Genmab as of February 03, 2023 is 38.26.
  • The all-time high Genmab stock closing price was 48.72 on September 03, 2021.
  • The Genmab 52-week high stock price is 47.50, which is 24.2% above the current share price.
  • The Genmab 52-week low stock price is 26.19, which is 31.5% below the current share price.
  • The average Genmab stock price for the last 52 weeks is 36.25.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Genmab Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2022 35.7757 39.6800 47.0600 26.8300 42.3800 7.13%
2021 40.7422 40.7600 48.7200 30.9200 39.5600 -2.71%
2020 30.8508 22.3000 40.7600 17.1500 40.6600 82.09%
2019 20.8930 18.1000 24.1400 18.0200 22.3300 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $25.237B $1.349B
Genmab A/S is a biotechnology company. It specializes in development of antibody therapeutics for the treatment of cancer. The company's product pipeline includes DARZALEX(R), Arzerra(R), tisotumab vedotin, enapotamab vedotin, HexaBody-DR5/DR5(R) and DuoBody-CD3xCD20 (R),which are in clinical stage. Genmab A/S is based in Copenhagen V, Denmark.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $158.293B 9.67
GSK (GSK) United Kingdom $71.300B 9.41
Bio-Rad Laboratories (BIO.B) United States $12.069B 28.64
QIAGEN (QGEN) Netherlands $11.249B 19.20
Ginkgo Bioworks Holdings (DNA) United States $3.996B 0.00
Myovant Sciences (MYOV) United Kingdom $2.614B 0.00
Arcus Biosciences (RCUS) United States $1.485B 22.29
Biohaven (BHVN) United States $1.240B 0.00
Emergent Biosolutions (EBS) United States $0.697B 5.48
ADC Therapeutics SA (ADCT) Switzerland $0.356B 0.00
Enzo Biochem (ENZ) United States $0.070B 0.00
Ambrx Biopharma (AMAM) United States $0.070B 0.00
SQZ Biotechnologies (SQZ) United States $0.024B 0.00
Gelesis Holdings (GLS) United States $0.024B 0.00